Clinical Trials Directory

Trials / Completed

CompletedNCT03544944

A Prospective, Randomized, Single-blinded (Evaluator), Parallel, Multi-center, Phase 3 Trial in Bowel Preparation for Colonoscopy

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
297 (actual)
Sponsor
Taejoon Pharmaceutical Co., Ltd. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This is a prospective randomized study compared with active control arm. The investigators compare the colon cleansing in patients undergoing colonoscopy.

Conditions

Interventions

TypeNameDescription
DRUGTJP-008-1Subjects who are randomized into group TJP-008-1 will receive bowel preparation on the same-day.
DRUGTJP-008-2Subjects who are randomized into group TJP-008-2 will receive bowel preparation from evening to next morning.
DRUGCoolprep powderSubjects who are randomized into group Coolprep will receive bowel preparation from evening to next morning.

Timeline

Start date
2018-01-02
Primary completion
2018-05-30
Completion
2018-07-30
First posted
2018-06-04
Last updated
2019-09-04

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03544944. Inclusion in this directory is not an endorsement.